Choosing the Best Option for Patients: Integrating GLP-1 RAs into Type 2 Diabetes Management
Wednesday May 9 12:10pm to 1:10pm
Diabetes Canada recommends that Canadian healthcare providers select a pharmacologic treatment for type 2 diabetes mellitus (T2DM) based on specific patient and agent characteristics, emphasizing individualization. With new and emerging therapies within the GLP-1 receptor agonist (GLP-1RA) class, and updates to the guidelines, participants will review the most recently available information and how it can be applied to clinical practice. Designed by a multidisciplinary committee comprised of family physicians, pharmacists and an endocrinologist, this program highlights common scenarios in which GLP-1RAs may be considered, and provides participants with an opportunity to “build” and discuss a patient case.
Assess the role of GLP-1 receptor agonist (GLP-1RA) therapy in T2DM, focusing on recommendations from Diabetes Canada.
Compare and contrast the efficacy, safety and dosing of current and upcoming GLP-1RAs.
Discuss how to integrate the GLP-1RA class into practice, reflecting on specific patient and agent characteristics to optimize T2DM management.
This Group Learning program has been reviewed by the College of Family Physicians of Canada and is awaiting final certification by the College’s Ontario Chapter.
This program was supported in part by an educational grant from Novo Nordisk.
Milan Gupta MD, FRCPC, FCCS Dr. Milan Gupta is a cardiologist certified by the Royal College of Physicians and Surgeons of Canada in both internal medicine and adult cardiology. He has also been certified by the American Society of Nuclear Cardiology, the Heart Rhythm Society, and the American Board of Internal Medicine. Dr. Gupta received his MD from the University of Toronto, where he then completed his residency in internal medicine and fellowship in cardiology. He runs a busy clinical practice in Brampton, ON (www.oslercardiology.com). He is an Associate Clinical Professor of Medicine at McMaster University in Hamilton, ON, and an Assistant Professor of Medicine at the University of Toronto. He is also the medical director of Brampton Research Associates, and has participated in over 100 large research trials as an investigator, or steering committee member.Dr. Gupta is actively engaged in clinical research, physician education, and professional advocacy. He holds a number of research grants and has published over 80 peer-reviewed manuscripts. He also serves on numerous professional advisory boards and guidelines writing committees. He is the Medical Director of the Canadian Collaborative Research Network (www.ccrnmd.com), and is past Treasurer and Executive Member of the Canadian Cardiovascular Society. He was co-founder and past chair of the Greater Toronto Area Community Cardiologists (GTACC), and past Board Member of the Cardiac Care Network of Ontario. He also chairs the Board of Directors of SANSAR (www.sansar.org), a national charity whose mission is to reduce the burden of cardiovascular disease in South Asians.
Dr. Gupta lectures widely on a variety of topics, and has a strong interest in developing innovative continuing medical education initiatives. His research interests include ethnicity and heart disease, atrial fibrillation, dyslipidemia, the interplay between diabetes, obesity and CV disease, and emerging risk factors in vascular disease. He is a recipient of the Dr. Harold Segal Award of Merit from the Canadian Cardiovascular Society, and the Colin Woolf Award for Excellence in Course Coordination from the University of Toronto.